Functional Abdominal Pain Clinical Trial
— FBIOfficial title:
Feelings and Body Investigators (FBI): Interoceptive Exposure for Child Abdominal Pain
Verified date | August 2020 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will provide tools to develop and pilot an intervention for Functional Abdominal Pain (FAP) using a ten session intervention with children ages 5-8. Investigators will train the subjects to be "Feeling and Body Investigators". During treatment phases the following will occur 1) gather clues (learn), 2) investigate (experience: perform interoceptive mystery missions to explore a body sensation), 3) organize body clues (contextualize: recall other contexts that evoke similar sensations), and 4) go on increasingly daring missions (challenge: decrease avoidance and safety behaviors). The FBI intervention will be developed and refined in 26 child-caregiver dyads during the current R21 phase. In the R33 phase investigators will randomize 100 subjects with FAP to FBI or an active control group in order to conduct a pilot-test of the feasibility, acceptance, and clinical significance of FBI. Young children with FAP who complete the FBI early intervention will learn to experience changes in the viscera as fun and fascinating, rather than scary, and will develop new capacities for pain management, adaptive functioning, and emotion regulation. For the R21 Phase (assessing initial feasibility) investigators hypothesize that ≥ 80% of participants enrolled in FBI will complete treatment and that ≥ 80% of participants will complete home-based practice assignments.
Status | Active, not recruiting |
Enrollment | 126 |
Est. completion date | September 2020 |
Est. primary completion date | September 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Months to 107 Months |
Eligibility |
Inclusion Criteria: - Child is between 60 and 107 months old. - Parent/legal guardian is present at the clinic visit who speaks English - Child screens positive for recurrent abdominal pain by having: 1) 8 episodes of abdominal pain over 2 months (based on Rome III criteria), or 2) 2 or more episodes of abdominal pain which are causing an incapacity greater than or equal to 25% of the time in the past two months). - Based on pediatric medical assessment, child meets criteria for functional abdominal pain (FAP) based on absence of other organic causes of recurrent abdominal pain. - Consent given by caregiver and assent by child to participate. - Presence of internet access, including that accessed by cell phone with video capabilities. Exclusion Criteria: - The index child being known to have mental retardation (IQ < 70) or other pervasive developmental disorders. - Subject has a sibling who is already enrolled in our study. ***Possible Exclusion*** - Parent/ guardian who would be participating in the study is pregnant. |
Country | Name | City | State |
---|---|---|---|
United States | Duke Children's Primary Care Picket Road | Durham | North Carolina |
United States | Duke University Young Child Lab at Brightleaf Square | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Duke University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of Participants Who Complete Treatment | Treatment in this study refers to10 treatment sessions (4 via webcam or over cell phone video chat from the subject's home and 6 in the investigator's lab) using an acceptance-based behavioral treatment for children 5 through 8 years old with impairing functional abdominal pain. This intervention is rooted in a biopsychosocial framework incorporating advances in neurodevelopment, behavioral learning theory, and attachment theory. | 1.5 Years | |
Primary | Percentage of Participants Completing Homework Assignment | Enrollees will engage in assigned home-based practice sessions for at least nine of the ten treatment weeks. Completion of assigned practice sessions within a given week is defined as success. | 1.5 Years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03558009 -
Epidemiological Analysis for Hereditary Angioedema Disease
|
||
Completed |
NCT03252743 -
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.
|
N/A | |
Completed |
NCT03901560 -
Music Therapy: Sickle Cell and Pain Crisis
|
||
Completed |
NCT02389998 -
Efficacy of Open Label Placebo in Children With FGIDs
|
N/A | |
Withdrawn |
NCT01269671 -
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain
|
Phase 1 | |
Recruiting |
NCT03823742 -
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
|
N/A | |
Completed |
NCT01118988 -
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
|
N/A | |
Completed |
NCT00876291 -
Efficacy of Lactobacillus GG (LGG) in Children With Abdominal Pain
|
N/A | |
Completed |
NCT04922476 -
Effect of 35624® Alflorex® in Functional Gastrointestinal Disorders (FGIDs) in Children.
|
N/A | |
Recruiting |
NCT01675050 -
A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain
|
Phase 2 | |
Active, not recruiting |
NCT02920268 -
Just in TIME - Intervention With Dance and Yoga for Girls With Recurrent Abdominal Pain
|
N/A | |
Completed |
NCT02113605 -
Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders
|
N/A | |
Completed |
NCT02872961 -
SIBO, Immune Activation, and FGIDs in Children
|
||
Completed |
NCT00327548 -
Use of Guided Imagery for Functional Abdominal Pain in Children:
|
Phase 3 |